NR3C2 has been described as a tumor suppressor in multiple malignancies, such as pancreatic, lung, colon, and renal cancers [57]; however, the prognostic value and biological effect of low NR3C2 level in BC remains unclear [58]. This evidence concerns the gene NR3C2 and neoplasm.